These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29705032)

  • 1. Diagnosis of multiple sclerosis through the lens of ultra-high-field MRI.
    Sati P
    J Magn Reson; 2018 Jun; 291():101-109. PubMed ID: 29705032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis.
    Inglese M; Fleysher L; Oesingmann N; Petracca M
    Expert Rev Neurother; 2018 Mar; 18(3):221-230. PubMed ID: 29369733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "kissing lesion": In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis.
    Kolber P; Droby A; Roebroeck A; Goebel R; Fleischer V; Groppa S; Zipp F
    Mult Scler; 2017 Jul; 23(8):1167-1169. PubMed ID: 28417657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging cortical lesions in multiple sclerosis.
    Mainero C; Treaba CA; Barbuti E
    Curr Opin Neurol; 2023 Jun; 36(3):222-228. PubMed ID: 37078649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
    Kilsdonk ID; Jonkman LE; Klaver R; van Veluw SJ; Zwanenburg JJ; Kuijer JP; Pouwels PJ; Twisk JW; Wattjes MP; Luijten PR; Barkhof F; Geurts JJ
    Brain; 2016 May; 139(Pt 5):1472-81. PubMed ID: 26956422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
    Jonkman LE; Fleysher L; Steenwijk MD; Koeleman JA; de Snoo TP; Barkhof F; Inglese M; Geurts JJ
    Mult Scler; 2016 Sep; 22(10):1306-14. PubMed ID: 26672996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T.
    Kollia K; Maderwald S; Putzki N; Schlamann M; Theysohn JM; Kraff O; Ladd ME; Forsting M; Wanke I
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):699-702. PubMed ID: 19147714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice.
    Bruschi N; Boffa G; Inglese M
    Eur Radiol Exp; 2020 Oct; 4(1):59. PubMed ID: 33089380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key clinical benefits of neuroimaging at 7T.
    Trattnig S; Springer E; Bogner W; Hangel G; Strasser B; Dymerska B; Cardoso PL; Robinson SD
    Neuroimage; 2018 Mar; 168():477-489. PubMed ID: 27851995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
    Chawla S; Kister I; Wuerfel J; Brisset JC; Liu S; Sinnecker T; Dusek P; Haacke EM; Paul F; Ge Y
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1223-30. PubMed ID: 27012298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging.
    Guglielmetti C; Boucneau T; Cao P; Van der Linden A; Larson PEZ; Chaumeil MM
    Neuroimage; 2020 Mar; 208():116415. PubMed ID: 31811900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.
    Beck ES; Sati P; Sethi V; Kober T; Dewey B; Bhargava P; Nair G; Cortese IC; Reich DS
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):459-466. PubMed ID: 29439120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.
    Harrison DM; Wang KY; Fiol J; Naunton K; Royal W; Hua J; Izbudak I
    J Neuroimaging; 2017 Sep; 27(5):461-468. PubMed ID: 28464368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-high field spinal cord MRI in multiple sclerosis: Where are we standing? A literature review.
    Kreiter DJ; van den Hurk J; Wiggins CJ; Hupperts RMM; Gerlach OHH
    Mult Scler Relat Disord; 2022 Jan; 57():103436. PubMed ID: 34871855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of cortical MS lesions with MRI need not be further improved - NO.
    Mainero C; Granberg T
    Mult Scler; 2017 Jan; 23(1):17-19. PubMed ID: 27566449
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative magnetic resonance imaging biomarkers for cortical pathology in multiple sclerosis at 7 T.
    Straub S; El-Sanosy E; Emmerich J; Sandig FL; Ladd ME; Schlemmer HP
    NMR Biomed; 2023 Mar; 36(3):e4847. PubMed ID: 36259249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced MRI and staging of multiple sclerosis lesions.
    Absinta M; Sati P; Reich DS
    Nat Rev Neurol; 2016 Jun; 12(6):358-68. PubMed ID: 27125632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.
    Dula AN; Pawate S; Dortch RD; Barry RL; George-Durrett KM; Lyttle BD; Dethrage LM; Gore JC; Smith SA
    Mult Scler; 2016 Mar; 22(3):320-8. PubMed ID: 26209591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of cortical MS lesions with MRI need not be further improved - YES.
    Geurts JJ; Chard DT
    Mult Scler; 2017 Jan; 23(1):15-17. PubMed ID: 27566450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.